Thyrocare has launched COVID-19 Antibody Test, in all major cities across India. This test is used for surveillance, to understand whether a person has encountered the infection in the recent past by assessing the antibodies produced by the immune system on exposure to the virus.

‘The antibody test for COVID-19 will help to understand what percentage of the population has been exposed to the virus and have developed antibodies to fight the virus.’

The procedure is fairly simple and does not require any fasting or precautionary measures. The test kits and procedures are priced at Rs 600 and the results can be obtained in 24 hours, It has been approved by the Indian Council of Medical Research (ICMR).




The test helps to detect the presence of antibodies against coronavirus, especially if the person has had any exposure to the virus in the past, primarily to check whether the immune system has responded well in the past. By undertaking the test, the percentage of population exposed to the infection can be detected, Hence, it is more of a sero-surveillance test than a diagnostic tool, because it helps to understand the spread of infection in the community.
Dr A Velumani, Founder and CEO, Thyrocare Technologies, said, "The antibody tests will equip us with data and information regarding the immunity levels of citizens in our country. We have conducted about 10,000 tests in cities where the virus is spreading rapidly in the last week out of which 6.8% of people have tested positive for the antibody tests."
"If your antibody test is positive, it goes on to prove that your immune system is excellent and gives you raised immunoglobulins. This gives you confidence and builds your morale. At Thyrocare, we are continuing our sustained efforts to make sure we do our bit in this fight against the virus," he said.
Thyrocare now conducts around 1,500 to 2,000 tests daily but it aims to raise it to 15,000 tests per day.
Advertisement